pubmed-article:10381114 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10381114 | lifeskim:mentions | umls-concept:C0036111 | lld:lifeskim |
pubmed-article:10381114 | lifeskim:mentions | umls-concept:C0683598 | lld:lifeskim |
pubmed-article:10381114 | lifeskim:mentions | umls-concept:C0449943 | lld:lifeskim |
pubmed-article:10381114 | lifeskim:mentions | umls-concept:C0016132 | lld:lifeskim |
pubmed-article:10381114 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:10381114 | pubmed:dateCreated | 1999-10-26 | lld:pubmed |
pubmed-article:10381114 | pubmed:abstractText | Antimicrobial resistance trends were examined for 811 salmonella isolates from humans collected in Finland during 1995-1997. The material was divided into domestic and foreign isolates according to the origin of infection. A total of 2.3% of the 387 domestic and 7.8% of the 424 foreign isolates were quinolone-resistant (P < 0.001). Among the domestic isolates we detected an emergence of ciprofloxacin resistance (MIC > or = 0.25 mg/L) with the proportion of resistant isolates increasing from 0 to 2.2% (P = 0.2). Among the foreign isolates this increase was even more dramatic, from 2.0% to 8.4% (P = 0.037) during the study period. | lld:pubmed |
pubmed-article:10381114 | pubmed:language | eng | lld:pubmed |
pubmed-article:10381114 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10381114 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10381114 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10381114 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10381114 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10381114 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10381114 | pubmed:month | Jan | lld:pubmed |
pubmed-article:10381114 | pubmed:issn | 0305-7453 | lld:pubmed |
pubmed-article:10381114 | pubmed:author | pubmed-author:KotilainenPP | lld:pubmed |
pubmed-article:10381114 | pubmed:author | pubmed-author:HuovinenPP | lld:pubmed |
pubmed-article:10381114 | pubmed:author | pubmed-author:SiitonenAA | lld:pubmed |
pubmed-article:10381114 | pubmed:author | pubmed-author:HakanenAA | lld:pubmed |
pubmed-article:10381114 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10381114 | pubmed:volume | 43 | lld:pubmed |
pubmed-article:10381114 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10381114 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10381114 | pubmed:pagination | 145-8 | lld:pubmed |
pubmed-article:10381114 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:10381114 | pubmed:meshHeading | pubmed-meshheading:10381114... | lld:pubmed |
pubmed-article:10381114 | pubmed:meshHeading | pubmed-meshheading:10381114... | lld:pubmed |
pubmed-article:10381114 | pubmed:meshHeading | pubmed-meshheading:10381114... | lld:pubmed |
pubmed-article:10381114 | pubmed:meshHeading | pubmed-meshheading:10381114... | lld:pubmed |
pubmed-article:10381114 | pubmed:meshHeading | pubmed-meshheading:10381114... | lld:pubmed |
pubmed-article:10381114 | pubmed:meshHeading | pubmed-meshheading:10381114... | lld:pubmed |
pubmed-article:10381114 | pubmed:meshHeading | pubmed-meshheading:10381114... | lld:pubmed |
pubmed-article:10381114 | pubmed:meshHeading | pubmed-meshheading:10381114... | lld:pubmed |
pubmed-article:10381114 | pubmed:meshHeading | pubmed-meshheading:10381114... | lld:pubmed |
pubmed-article:10381114 | pubmed:meshHeading | pubmed-meshheading:10381114... | lld:pubmed |
pubmed-article:10381114 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10381114 | pubmed:articleTitle | Increasing fluoroquinolone resistance in salmonella serotypes in Finland during 1995-1997. | lld:pubmed |
pubmed-article:10381114 | pubmed:affiliation | Antimicrobial Research Laboratory, National Public Health Institute, Turku, Finland. antti.hakanen@utu.fi | lld:pubmed |
pubmed-article:10381114 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10381114 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10381114 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10381114 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10381114 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10381114 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10381114 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10381114 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10381114 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10381114 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10381114 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10381114 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10381114 | lld:pubmed |